BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wuorimaa T, Käyhty H. Current State of Pneumococcal Vaccines: Current State of Pneumococcal Vaccines. Scandinavian Journal of Immunology 2002;56:111-29. [DOI: 10.1046/j.1365-3083.2002.01124.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 2.4] [Reference Citation Analysis]
Number Citing Articles
1 Reinert RR. Pneumococcal conjugate vaccines—a European perspective. International Journal of Medical Microbiology 2004;294:277-94. [DOI: 10.1016/j.ijmm.2004.04.004] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 2.7] [Reference Citation Analysis]
2 García-Suárez Mdel M, Cima-Cabal MD, Flórez N, García P, Cernuda-Cernuda R, Astudillo A, Vázquez F, De los Toyos JR, Méndez FJ. Protection against pneumococcal pneumonia in mice by monoclonal antibodies to pneumolysin. Infect Immun 2004;72:4534-40. [PMID: 15271913 DOI: 10.1128/IAI.72.8.4534-4540.2004] [Cited by in Crossref: 51] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
3 Quataert SA, Rittenhouse-Olson K, Kirch CS, Hu B, Secor S, Strong N, Madore DV. Assignment of weight-based antibody units for 13 serotypes to a human antipneumococcal standard reference serum, lot 89-S(f). Clin Diagn Lab Immunol 2004;11:1064-9. [PMID: 15539507 DOI: 10.1128/CDLI.11.6.1064-1069.2004] [Cited by in Crossref: 56] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
4 Karppa H, Vuento R, Toropainen M, Kaijalainen T, Siira L, Korppi M. Pneumococcemia in children - a retrospective study before universal pneumococcal vaccinations. Acta Paediatr 2013;102:514-9. [DOI: 10.1111/apa.12194] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
5 Haas KM, Poe JC, Tedder TF. CD21/35 promotes protective immunity to Streptococcus pneumoniae through a complement-independent but CD19-dependent pathway that regulates PD-1 expression. J Immunol 2009;183:3661-71. [PMID: 19710450 DOI: 10.4049/jimmunol.0901218] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 1.7] [Reference Citation Analysis]
6 Ling E, Feldman G, Portnoi M, Dagan R, Overweg K, Mulholland F, Chalifa-Caspi V, Wells J, Mizrachi-Nebenzahl Y. Glycolytic enzymes associated with the cell surface of Streptococcus pneumoniae are antigenic in humans and elicit protective immune responses in the mouse. Clin Exp Immunol 2004;138:290-8. [PMID: 15498039 DOI: 10.1111/j.1365-2249.2004.02628.x] [Cited by in Crossref: 151] [Cited by in F6Publishing: 143] [Article Influence: 8.4] [Reference Citation Analysis]
7 Jakobsen H, Jonsdottir I. Mucosal Vaccination Against Encapsulated Respiratory Bacteria - New Potentials for Conjugate Vaccines? Scand J Immunol 2003;58:119-28. [DOI: 10.1046/j.1365-3083.2003.01292.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 1.7] [Reference Citation Analysis]
8 Jang AY, Ahn KB, Zhi Y, Ji HJ, Zhang J, Han SH, Guo H, Lim S, Song JY, Lim JH, Seo HS. Serotype-Independent Protection Against Invasive Pneumococcal Infections Conferred by Live Vaccine With lgt Deletion. Front Immunol 2019;10:1212. [PMID: 31191555 DOI: 10.3389/fimmu.2019.01212] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
9 Yu J, Lin J, Benjamin WH Jr, Waites KB, Lee CH, Nahm MH. Rapid multiplex assay for serotyping pneumococci with monoclonal and polyclonal antibodies. J Clin Microbiol 2005;43:156-62. [PMID: 15634965 DOI: 10.1128/JCM.43.1.156-162.2005] [Cited by in Crossref: 36] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
10 Liu CI, Mulani S, Mong KT. Iterative One-Pot α-Glycosylation Strategy: Application to Oligosaccharide Synthesis. Adv Synth Catal 2012;354:3299-310. [DOI: 10.1002/adsc.201200396] [Cited by in Crossref: 20] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
11 Rüggeberg J, Heath PT. Safety and efficacy of meningococcal group C conjugate vaccines. Expert Opin Drug Saf 2003;2:7-19. [PMID: 12904121 DOI: 10.1517/14740338.2.1.7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
12 Baraldo K, Mori E, Bartoloni A, Petracca R, Giannozzi A, Norelli F, Rappuoli R, Grandi G, Del Giudice G. N19 polyepitope as a carrier for enhanced immunogenicity and protective efficacy of meningococcal conjugate vaccines. Infect Immun 2004;72:4884-7. [PMID: 15271954 DOI: 10.1128/IAI.72.8.4884-4887.2004] [Cited by in Crossref: 21] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
13 Huang Y, Wu C. Carbohydrate-based vaccines: challenges and opportunities. Expert Review of Vaccines 2014;9:1257-74. [DOI: 10.1586/erv.10.120] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 4.8] [Reference Citation Analysis]
14 Peppoloni S, Colombari B, Neglia R, Quaglino D, Iannelli F, Oggioni MR, Pozzi G, Blasi E. The lack of Pneumococcal surface protein C (PspC) increases the susceptibility of Streptococcus pneumoniae to the killing by microglia. Med Microbiol Immunol 2006;195:21-8. [PMID: 15909201 DOI: 10.1007/s00430-005-0243-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
15 Lucero MG, Dulalia VE, Parreno RN, Lim-Quianzon DM, Nohynek H, Makela H, Williams G. Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and pneumonia with consolidation on x-ray in children under two years of age. Cochrane Database Syst Rev 2004;:CD004977. [PMID: 15495133 DOI: 10.1002/14651858.CD004977] [Cited by in Crossref: 24] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
16 Blue CE, Mitchell TJ. Contribution of a response regulator to the virulence of Streptococcus pneumoniae is strain dependent. Infect Immun 2003;71:4405-13. [PMID: 12874319 DOI: 10.1128/IAI.71.8.4405-4413.2003] [Cited by in Crossref: 44] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
17 Hatz CF, Bally B, Rohrer S, Steffen R, Kramme S, Siegrist CA, Wacker M, Alaimo C, Fonck VG. Safety and immunogenicity of a candidate bioconjugate vaccine against Shigella dysenteriae type 1 administered to healthy adults: A single blind, partially randomized Phase I study. Vaccine 2015;33:4594-601. [PMID: 26162850 DOI: 10.1016/j.vaccine.2015.06.102] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 7.3] [Reference Citation Analysis]
18 Karki G, Kumar Mandal P. Synthetic directions towards capsular polysaccharide of Streptococcus pneumoniae serotype 18C. Tetrahedron Letters 2019;60:151153. [DOI: 10.1016/j.tetlet.2019.151153] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
19 Clatworthy MR, Smith KG. FcgammaRIIb balances efficient pathogen clearance and the cytokine-mediated consequences of sepsis. J Exp Med 2004;199:717-23. [PMID: 14981111 DOI: 10.1084/jem.20032197] [Cited by in Crossref: 101] [Cited by in F6Publishing: 98] [Article Influence: 5.6] [Reference Citation Analysis]
20 Yu J, Carvalho MDGS, Beall B, Nahm MH. A rapid pneumococcal serotyping system based on monoclonal antibodies and PCR. J Med Microbiol 2008;57:171-8. [PMID: 18201982 DOI: 10.1099/jmm.0.47549-0] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 3.0] [Reference Citation Analysis]
21 Cole JN, Henningham A, Gillen CM, Ramachandran V, Walker MJ. Human pathogenic streptococcal proteomics and vaccine development. Proteomics Clin Appl 2008;2:387-410. [PMID: 21136841 DOI: 10.1002/prca.200780048] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
22 Alexander J, Guercio MD, Frame B, Maewal A, Sette A, Nahm MH, Newman MJ. Development of experimental carbohydrate-conjugate vaccines composed of Streptococcus pneumoniae capsular polysaccharides and the universal helper T-lymphocyte epitope (PADRE®). Vaccine 2004;22:2362-7. [DOI: 10.1016/j.vaccine.2003.11.061] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 1.9] [Reference Citation Analysis]
23 Haas KM. Programmed cell death 1 suppresses B-1b cell expansion and long-lived IgG production in response to T cell-independent type 2 antigens. J Immunol 2011;187:5183-95. [PMID: 22003198 DOI: 10.4049/jimmunol.1101990] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 3.5] [Reference Citation Analysis]
24 Peppoloni S, Colombari B, Beninati C, Felici F, Teti G, Speziale P, Ricci S, Ardizzoni A, Manca L, Blasi E. The Spr1875 protein confers resistance to the microglia-mediated killing of Streptococcus pneumoniae. Microb Pathog 2013;59-60:42-7. [PMID: 23587464 DOI: 10.1016/j.micpath.2013.04.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
25 Bjarnarson SP, Jakobsen H, Del Giudice G, Trannoy E, Siegrist CA, Jonsdottir I. The advantage of mucosal immunization for polysaccharide-specific memory responses in early life. Eur J Immunol 2005;35:1037-45. [PMID: 15756644 DOI: 10.1002/eji.200425850] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 1.8] [Reference Citation Analysis]
26 Racine R, Winslow GM. IgM in microbial infections: taken for granted? Immunol Lett 2009;125:79-85. [PMID: 19539648 DOI: 10.1016/j.imlet.2009.06.003] [Cited by in Crossref: 145] [Cited by in F6Publishing: 136] [Article Influence: 11.2] [Reference Citation Analysis]
27 Jones HE, Taylor PR, Mcgreal E, Zamze S, Wong SY. The contribution of naturally occurring IgM antibodies, IgM cross-reactivity and complement dependency in murine humoral responses to pneumococcal capsular polysaccharides. Vaccine 2009;27:5806-15. [DOI: 10.1016/j.vaccine.2009.07.063] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
28 Joshi VS, Bajaj IB, Survase SA, Singhal RS, Kennedy JF. Meningococcal polysaccharide vaccines: A review. Carbohydrate Polymers 2009;75:553-65. [DOI: 10.1016/j.carbpol.2008.09.032] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
29 Frazão N, Brito-Avô A, Simas C, Saldanha J, Mato R, Nunes S, Sousa NG, Carriço JA, Almeida JS, Santos-Sanches I, de Lencastre H. Effect of the seven-valent conjugate pneumococcal vaccine on carriage and drug resistance of Streptococcus pneumoniae in healthy children attending day-care centers in Lisbon. Pediatr Infect Dis J 2005;24:243-52. [PMID: 15750461 DOI: 10.1097/01.inf.0000154326.77617.3e] [Cited by in Crossref: 77] [Cited by in F6Publishing: 66] [Article Influence: 4.5] [Reference Citation Analysis]
30 Engel P, Gómez-Puerta JA, Ramos-Casals M, Lozano F, Bosch X. Therapeutic targeting of B cells for rheumatic autoimmune diseases. Pharmacol Rev 2011;63:127-56. [PMID: 21245206 DOI: 10.1124/pr.109.002006] [Cited by in Crossref: 72] [Cited by in F6Publishing: 64] [Article Influence: 6.5] [Reference Citation Analysis]
31 Jónsdóttir I. Maturation of Mucosal Immune Responses and Influence of Maternal Antibodies. Journal of Comparative Pathology 2007;137:S20-6. [DOI: 10.1016/j.jcpa.2007.04.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
32 Barocchi MA, Censini S, Rappuoli R. Vaccines in the era of genomics: the pneumococcal challenge. Vaccine 2007;25:2963-73. [PMID: 17324490 DOI: 10.1016/j.vaccine.2007.01.065] [Cited by in Crossref: 65] [Cited by in F6Publishing: 59] [Article Influence: 4.3] [Reference Citation Analysis]
33 Parameswar AR, Pornsuriyasak P, Lubanowski NA, Demchenko AV. Efficient stereoselective synthesis of oligosaccharides of Streptococcus pneumoniae serotypes 6A and 6B containing multiple 1,2-cis glycosidic linkages. Tetrahedron 2007;63:10083-91. [DOI: 10.1016/j.tet.2007.07.036] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
34 Khalid A, Asim-Ur-Rehman, Ahmed N, Chaudhery I, Al-Jafary MA, Al-Suhaimi EA, Tarhini M, Lebaz N, Elaissari A. Polysaccharide Chemistry in Drug Delivery, Endocrinology, and Vaccines. Chemistry 2021;27:8437-51. [PMID: 33856737 DOI: 10.1002/chem.202100204] [Reference Citation Analysis]
35 Dowson CG. What is a Pneumococcus? In: Tuomanen EI, Mitchell TJ, Morrison D, Spratt BG, editors. The Pneumococcus. Washington: ASM Press; 2004. pp. 1-14. [DOI: 10.1128/9781555816537.ch1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
36 Parameswar AR, Park IH, Saksena R, Kovác P, Nahm MH, Demchenko AV. Synthesis, conjugation, and immunological evaluation of the serogroup 6 pneumococcal oligosaccharides. Chembiochem 2009;10:2893-9. [PMID: 19856369 DOI: 10.1002/cbic.200900587] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
37 Haas KM, Poe JC, Steeber DA, Tedder TF. B-1a and B-1b Cells Exhibit Distinct Developmental Requirements and Have Unique Functional Roles in Innate and Adaptive Immunity to S. pneumoniae. Immunity 2005;23:7-18. [DOI: 10.1016/j.immuni.2005.04.011] [Cited by in Crossref: 404] [Cited by in F6Publishing: 383] [Article Influence: 23.8] [Reference Citation Analysis]
38 Karupiah G, Chaudhri G. Immunopathogenesis of infectious disease: injury and death from friendly fire. Immunol Cell Biol 2007;85:5. [PMID: 17203109 DOI: 10.1038/sj.icb.7100016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
39 Nurkka A, Joensuu J, Henckaerts I, Peeters P, Poolman J, Kilpi T, Kayhty H. Immunogenicity and safety of the eleven valent pneumococcal polysaccharide-protein D conjugate vaccine in infants. Pediatr Infect Dis J. 2004;23:1008-1014. [PMID: 15545855 DOI: 10.1097/01.inf.0000143640.03214.18] [Cited by in Crossref: 51] [Cited by in F6Publishing: 44] [Article Influence: 3.0] [Reference Citation Analysis]
40 Capeding MZ, Puumalainen T, Gepanayao CP, Käyhty H, Lucero MG, Nohynek H. Safety and immunogenicity of three doses of an eleven-valent diphtheria toxoid and tetanus protein--conjugated pneumococcal vaccine in Filipino infants. BMC Infect Dis 2003;3:17. [PMID: 12908876 DOI: 10.1186/1471-2334-3-17] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 0.9] [Reference Citation Analysis]
41 Parameswar AR, Hasty SJ, Demchenko AV. Synthesis of spacer-containing analogs of serogroup 6 pneumococcal oligosaccharides. Carbohydr Res 2008;343:1707-17. [PMID: 18439990 DOI: 10.1016/j.carres.2008.03.035] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
42 Aradottir Pind AA, Molina Estupiñan JL, Magnusdottir GJ, Del Giudice G, Jonsdottir I, Bjarnarson SP. LT-K63 Enhances B Cell Activation and Survival Factors in Neonatal Mice That Translates Into Long-Lived Humoral Immunity. Front Immunol 2020;11:527310. [PMID: 33193301 DOI: 10.3389/fimmu.2020.527310] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
43 Jakobsen H, Hannesdottir S, Bjarnarson S, Schulz D, Trannoy E, Siegrist C, Jonsdottir I. Early life T cell responses to pneumococcal conjugates increase with age and determine the polysaccharide-specific antibody response and protective efficacy. Eur J Immunol 2006;36:287-95. [DOI: 10.1002/eji.200535102] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
44 Lecrenier N, Marijam A, Olbrecht J, Soumahoro L, Nieto Guevara J, Mungall B. Ten years of experience with the pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine ( Synflorix ) in children. Expert Review of Vaccines 2020;19:247-65. [DOI: 10.1080/14760584.2020.1738226] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
45 Lin J, Kaltoft MS, Brandao AP, Echaniz-Aviles G, Brandileone MC, Hollingshead SK, Benjamin WH, Nahm MH. Validation of a multiplex pneumococcal serotyping assay with clinical samples. J Clin Microbiol 2006;44:383-8. [PMID: 16455888 DOI: 10.1128/JCM.44.2.383-388.2006] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]